Impact of Covid-19 Treatment on Oral Cavity
Saurabh Prakash and Veena Naik*
Department of Oral Medicine and Maxillofacial Radiology, AIMST University, Malaysia
*Corresponding Author: Veena Naik, Department of Oral Medicine and Maxillofacial Radiology, AIMST University, Malaysia.
Received: October 03, 2022; Published: October 18, 2022
Severe infectious disease Coronavirus disease 2019 (COVID-19) led to worldwide pandemic. Starting with mild flu to attacking the respiratory system or even death are the symptoms of this disease. Dentists are regarded to be the highest risk group of healthcare workers for contracting COVID-19, due to the nature of their work. it becomes mandatory for the dentists to be aware of the oral side effects caused by the medications used in prolonged treatment of COVID‐19. We have discussed few of the medications used in treating Covid -19, that leads to changes in the oral cavity. Hence, we should not underestimate the effects of intense and complex pharmacotherapy while evaluating patient's oral health. Therefore, Oral medicine and pathology facilities should take a call in detecting and managing these lesions.
Keywords: Coronavirus Disease 2019 (COVID-19); Dental/Oral Problems; Drugs used in Treating Covid-19; Oral Medicine and Pathology Specialists
- Hui DS., et al. "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China". International Journal of Infectious Diseases 91 (2020): 264-266.
- Yang Y., et al. "The deadly coronaviruses: the 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China”. Journal of Autoimmunity 109 (2020): 102434.
- R S-Silva., et al. "Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis”. Clinical Oral Investigations 24.4 (2020): 1619-1621.
- Izzetti M Nisi., et al. "COVID-19 Transmission in Dental Practice: Brief Review of Preventive Measures in Italy”. Journal of Dental Research (2020): 1-9.
- To KK., et al. "Consistent detection of 2019 novel coronavirus in saliva”. Clinical Infectious Diseases 71.15 (2020): 841-843.
- American Dental Association. “ADA calls on dentists to postpone elective procedures” (2020).
- Mahase E. “Covid‐19: What treatments are being investigated?” BMJ 368 (2020):
- Sayburn A. “Covid‐19: Trials of four potential treatments to generate “robust data” of what works”. BMJ 368 (2020):
- Gao J., et al. "Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID‐19 associated pneumonia in clinical studies”. BioScience Trends1 (2020): 72-73.
- Horta-Baas G. “Chloroquine-induced oral mucosal hyperpigmentation and nail dyschromia”. Reumatología Clínica 14 (2018): 177-178.
- Moraes PC., et al. "Pigmented lichenoid drug eruption secondary to chloroquine therapy: An unusual presentation in lower lip”. Minerva Stomatologica 60 (2011): 327-332.
- Chu CM., et al. HKU/UCH SARS Study Group. “Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings”. Thorax 59 (2004): 252-256.
- NHS England. “Acute Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in People with or at Risk of COVID-19 (RPS2001)” (2020).
- Xu H., et al. "High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa”. International Journal of Oral Science 12 (2020): 1-5.
- Van Riel D., et al. "The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system”. The Journal of Pathology 235 (2020): 277-287.
- Baboor AS., et al. "Unconventional materials and substances used in water pipe (narghile) by smokers in central western region, Saudi Arabia”. Saudi Medical Journal 35 (2020): 890-893.
- Castrejon-Perez A., et al. "Cutaneous Mucormycosis”. Brasileiros De Dermatologia 92 (2017): 304-311.